Key result
A cell-based fluorescent screening assay using HL-1 cells successfully identified analogues of amiloride and propafenone as GIRK1/4 channel blockers at concentrations <1 µM.
A newly developed cell-based fluorescent screening assay successfully identifies GIRK1/4 channel blockers, providing a tool for discovering novel atrial fibrillation therapies.
Answers are grounded in this paper and cite their sources.
May accelerate GIRK1/4 blocker discovery for AF; leaves open translation to clinical efficacy and safety.
The cardiac acetylcholine-activated K(+) channel (I(K,Ach)) represents a novel target for drug therapy in the treatment of atrial fibrillation (AF). This channel is a member of the G-protein-coupled inward rectifier K(+) (GIRK) channel superfamily and is composed of the GIRK1/4 (Kir3.1 and Kir3.4) subunits. The goal of this study was to develop a cell-based screening assay for identifying new blockers of the GIRK1/4 channel. The mouse atrial HL-1 cell line, expressing the GIRK1/4 channel, was plated in 96-well plate format, loaded with the fluorescent membrane potential-sensitive dye bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC(4)(3)) and measured using a fluorescent imaging plate reader (FLIPR). Application of the muscarinic agonist carbachol to the cells caused a rapid, time-dependent decrease in the fluorescent signal, indicative of K(+) efflux through the GIRK1/4 channel (carbachol vs. control solution, Z' factor = 0.5-0.6). The GIRK1/4 channel fluorescent signal was blocked by BaCl(2) and enhanced by increasing the driving force for K(+) across the cell membrane. To test the utility of the assay for screening GIRK1/4 channel blockers, cells were treated with a small compound library of Na(+) and K(+) channel modulators. Analogues of amiloride and propafenone were identified as channel blockers at concentrations less than 1 µM. Thus, the GIRK1/4 channel assay may be used in the development of new and selective agents for treating AF.
No takes yet. Share an insight, caveat, or question.
Kenneth B. Walsh (2010) studied Atrial fibrillation. Small compound library of Na(+) and K(+) channel modulators vs. Control solution was evaluated on Fluorescent signal indicative of K(+) efflux through the GIRK1/4 channel (Z' factor = 0.5-0.6). A cell-based fluorescent screening assay using HL-1 cells successfully identified analogues of amiloride and propafenone as GIRK1/4 channel blockers at concentrations <1 µM.
Synapse has enriched 10 related papers. Consider them for comparative context: